Trials / Conditions / EGFR-TKI
EGFR-TKI
4 registered clinical trials studyying EGFR-TKI — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs NCT06766591 | Jiangsu Province Nanjing Brain Hospital | N/A |
| Recruiting | Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia NCT06643416 | Queen Mary Hospital, Hong Kong | Phase 3 |
| Unknown | Neoadjuvant Afatinib Combination With Chemotherapy for Stage Ⅱa-Ⅲb NSCLC With EGFR Activating Mutation NCT04470076 | Fifth Affiliated Hospital, Sun Yat-Sen University | Phase 2 |
| Unknown | Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC NCT03428022 | Shenzhen People's Hospital | Phase 3 |